Key result
KDIGO guideline delivers evidence-based recommendations for contrast-induced AKI and renal replacement therapy.
Answers are grounded in this paper and cite their sources.
Acute kidney injury (AKI) is a common and serious problem affecting millions and causing death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes completed the first ever international multidisciplinary clinical practice guideline for AKI. The guideline is based on evidence review and appraisal, and covers AKI definition, risk assessment, evaluation, prevention, and treatment. Two topics, contrast-induced AKI and management of renal replacement therapy, deserve special attention because of the frequency in which they are encountered and the availability of evidence. Recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the Grading of Recommendations Assessment, Development and Evaluation approach. Limitations of the evidence are discussed and a detailed rationale for each recommendation is provided. This review is an abridged version of the guideline and provides additional rationale and commentary for those recommendation statements that most directly impact the practice of critical care.
No takes yet. Share an insight, caveat, or question.
Lameire et al. (2013) conducted a review in Acute kidney injury (AKI), including contrast-induced AKI. Renal replacement therapy and management of contrast-induced acute kidney injury was evaluated. The 2012 KDIGO clinical practice guideline provides GRADE-appraised recommendations for contrast-induced acute kidney injury and renal replacement therapy management in critical care.
Synapse has enriched 10 related papers. Consider them for comparative context: